Introduction {#s0005}
============

Studies have defined a genetic 'bottleneck' at mucosal HIV-1 transmission with a single inferred variant initiating peripheral viremia in most cases ([@bib3; @bib7; @bib12; @bib20; @bib22; @bib26]). In particular it has been noted that transmitted founder (T/F) Envelope proteins are R5 tropic with both increased sensitivity to broadly neutralizing antibodies ([@bib36]) and reduced ability to interact with maraviroc-bound CCR5 compared to viruses isolated from chronic infection ([@bib21]). Furthermore, preferential transmission of ancestral as opposed to contemporary strains in donor individuals has been reported ([@bib25]), suggesting specific viral determinants for sexual transmission that differ from determinants for propagation of chronic infection. Intriguingly, it has been reported that T/F viruses are less restricted by interferon (IFN) in primary T cells than chronic controls ([@bib7; @bib22]).

Lentiviral accessory proteins have evolved the ability to mitigate the detrimental effects of an IFN-induced antiviral immune response by interfering with various host immunity factors ([@bib13; @bib18; @bib31]). For example, HIV-1 Vpu and Vif counteract the IFN-inducible restriction factors tetherin/BST-2/CD317 ([@bib19; @bib34]) and APOBEC3D/F/G, respectively ([@bib4; @bib14; @bib32; @bib37]). Vpu also prevents expression of IFN and IFN-stimulated genes by inhibiting the activation of NF-κB ([@bib5; @bib28]), and Nef is known to modulate a range of host immune receptors including CD4 and MHC molecules ([@bib16]).

We hypothesized that accessory gene(s) from T/F viruses confer advantages to establishment and early propagation of HIV-1 infection either through counteraction of IFN-stimulated genes or modulation of ligands known to activate NK, NKT and other immune cells. We therefore directly compared functional activities of the accessory proteins Vpu, Vif and Nef from six T/F and six CC viruses (see [Table 1](#t0005){ref-type="table"} for patient characteristics and [Supplementary Figs. 1--3](#s0090){ref-type="fn"} for multiple sequence alignments).

Results {#s0010}
=======

Counteraction of tetherin/BST-2/CD317 and NF-κB activation by Vpu {#s0015}
-----------------------------------------------------------------

Vpu proteins from T/F and CC viruses were tested for their ability to increase virion release by counteracting tetherin/BST-2/CD317. Tetherin serves as a physical tether between viral and cellular membranes and inhibits the egress of budding virions from infected cells. All Vpus were expressed ([Fig. 1](#f0005){ref-type="fig"}A) and enabled efficient virus release from tetherin expressing HEK293T cells. Anti-tetherin activity was similar for Vpus from T/F and CC viruses (*p*=0.51, [Fig. 1](#f0005){ref-type="fig"}B), consistent with a previous study demonstrating conservation of tetherin antagonism over extended periods in chronically infected patients ([@bib24]).

Tetherin does not only restrict virion release but also acts as an innate sensor activating NF-κB-dependent expression of type I IFN and IFN-stimulated genes ([@bib9]). We therefore investigated whether T/F Vpus are more efficient in blocking tetherin signaling than Vpus from CC viruses. A dual luciferase reporter assay in HEK293T cells revealed that all Vpus efficiently inhibited the activation of NF-κB with no significant differences between the T/F and CC groups (*p*=0.81, [Fig. 1](#f0005){ref-type="fig"}C). Since Vpu has also been reported to block activation of NF-κB independently of tetherin ([@bib5; @bib28]), we repeated the experiment using a constitutively active mutant of IKKβ instead of tetherin as the inducer. Again, T/F and CC Vpus suppressed NF-κB activation to similar degrees (*p*=0.31, [Fig. 1](#f0005){ref-type="fig"}D).

Cell surface downregulation of CD4, NTB-A and CD1d by Vpu {#s0020}
---------------------------------------------------------

Besides counteracting tetherin and inhibiting NF-κB activation, Vpu also decreases cell surface expression of CD4, NTB-A and CD1d. While downmodulation of CD4 prevents superinfection and enables the release of fully infectious progeny virions from infected cells ([@bib15; @bib17; @bib35]), downmodulation of NTB-A and CD1d has been suggested to protect HIV-1 infected cells from NK or NKT cell mediated killing, respectively ([@bib18; @bib31]). Using flow cytometry, we monitored expression of these receptors on the surface of HEK293T cells transfected with Vpu or a vector control. Vpu reduced surface levels of all three receptors as expected, without significant differences between T/F and CC viruses (CD4: *p*=0.84, NTB-A: *p*=0.61, CD1d: *p*=0.34, [Fig. 1](#f0005){ref-type="fig"}E--J).

Counteraction of APOBEC3F/G by Vif {#s0025}
----------------------------------

The accessory protein Vif induces the ubiquitination and subsequent degradation of the restriction factors APOBEC3DF/G/H to prevent their incorporation into viral particles ([@bib4; @bib14; @bib32]). APOBEC3F/G are cytidine deaminases, inhibiting HIV-1 replication through G to A hypermutation of viral cDNA as well as direct inhibition of reverse transcription itself ([@bib11]). We analyzed the activity of T/F and CC Vif proteins against human APOBEC3F and APOBEC3G by co-transfecting HEK293T cells with plasmids encoding *vif*-deficient HIV-1 along with APOBEC3F or APOBEC3G and *vif* alleles/empty plasmid. As Vif expression/ stability varied between alleles tested, the amount of Vif expression plasmid was modified in order to achieve similar amounts of Vif protein in the producer cells ([Fig. 2](#f0010){ref-type="fig"}A). Under these conditions the infectivity of supernatant viruses was determined, revealing that Vifs from T/F and CC viruses have equivalent activity against APOBEC3F and APOBEC3G ([Fig. 2](#f0010){ref-type="fig"}B and C).

Cell surface downregulation of CD4, CD28 and MHC class I by Nef {#s0030}
---------------------------------------------------------------

The accessory protein Nef downregulates various cell surface proteins including CD4, MHC class I and CD28 to escape immune surveillance ([@bib10; @bib30; @bib33]) and may thus also be involved in the reduced sensitivity of T/F viruses to IFN. CD4 and CD28 downregulation were analyzed by transient transfection of HEK293T cells with vectors expressing Nef and either CD4 or CD28. All Nef proteins were efficiently expressed ([Fig. 3](#f0015){ref-type="fig"}A) and reduced surface expression of both receptors with no significant differences between T/F and CC viruses (CD4: *p*=0.71, CD28: *p*=0.76, [Fig. 3](#f0015){ref-type="fig"}B--E). To explore MHC class I downregulation, a HeLa cell line expressing HLA-B^⁎^27 was transfected with different *nef* alleles and MHC class I cell surface expression was analyzed by FACS 48 h post-transfection. Nef proteins of both groups of viruses downmodulated MHC class I to a similar extent (*p*=0.22, [Fig. 3](#f0015){ref-type="fig"}F and G).

Nef-mediated enhancement of virion infectivity {#s0035}
----------------------------------------------

It has been shown that HIV-1 virion infectivity is reduced in the absence of a functional *nef* gene ([@bib1; @bib6]). We thus tested the effect of Nef proteins on virion infectivity by transfecting HEK293T cells with *nef* alleles and *nef*-deficient HIV-1 NL4-3. Supernatants harvested two days post-transfection were used to infect indicator TZM-bl cells with normalized amounts of p24. Despite variation between individual Nef proteins in their ability to enhance virion infectivity, there was no statistical difference when T/F and CC Nefs were compared (*p*=0.77, [Fig. 3](#f0015){ref-type="fig"}H).

Discussion {#s0040}
==========

In summary, our results show that established functions of the accessory proteins Vpu, Vif and Nef are conserved across T/F and CC viruses. Specifically, our results from transient expression studies suggest that the increased IFN resistance of newly transmitted HIV-1 strains is not the result of a particularly efficient Vpu-mediated inhibition of NF-κB activation or counteraction of the restriction factors tetherin and APOBEC3F/G. An important limitation is that viral proteins were not expressed from a provirus in our experiments, and therefore it is possible that *in vivo* expression may differ.

The identification of traits that are shared by T/F viruses may ultimately provide novel targets for strategies aiming to prevent the acquisition of HIV-1 at mucosal surfaces. Thus, further analyses of accessory viral gene function in primary human cells and systematic comparison of other HIV-1 gene products are highly warranted to decipher the reason(s) for the increased IFN resistance and selection advantage of T/F viruses during transmission and acute infection.

Materials and methods {#s0045}
=====================

Cell culture and transfections {#s0050}
------------------------------

HEK293T, TZM-bl and HeLa.B27 cells were grown under standard conditions in Dulbecco׳s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum, 120 mg/ml streptomycin, 120 mg/ml penicillin and 2 mM [l]{.smallcaps}-glutamine. Cells were transfected using the calcium-phosphate precipitation method, polyethyleneimine (PEI) or Fugene 6 (Roche Applied Science).

Expression vectors {#s0055}
------------------

Vpu, Nef, CD1d, CD4, NTB-A (transcript variant 2) and BST-2/tetherin alleles were cloned into the CMV-promoter-based pCG expression vector, *vpu* and *nef* encoding vectors co-expressing eGFP or DsRed via an IRES as previously described ([@bib29]). CD28 was cloned into in a pcDNA3.1+ vector. HA-tagged subtype B and C Vif alleles were amplified from transmitted/founder and chronic full-length IMCs (infectious molecular clones) kindly provided by Beatrice Hahn and cloned into pcDNA3.1 using NotI and XhoI restriction sites. The plasmids encoding T7-A3F/G have been previously described ([@bib2]). The firefly luciferase reporter plasmid containing three NF-κB binding sites as well as the constitutively active mutant of IKKβ were kindly provided by Bernd Baumann. A minimal promoter *gaussia* luciferase construct was purchased from Clontech (\#631909) and used for normalization. It contains the TATA-like promoter (pTAL) region from the Herpes simplex virus thymidine kinase (HSV-TK) that is not responsive to NF-κB.

Western blotting {#s0060}
----------------

Protein expression was assessed by standard immunoblots using anti AU-1 antibody (bs-2114R, Bioss) to detect AU1 tagged Vpu and Nef proteins or anti HA (3F10, Roche) to identify HA-tagged Vif. Anti-HSP90 (H114, Santa Cruz Biotechnology) and anti-actin antibody (AC-15, Abcam) were used to detect the loading control proteins.

Flow cytometry {#s0065}
--------------

To determine the effect of Vpu on CD1d or NTB-A, HEK293T cells were transfected with 1 μg of the CD1d or NTB-A expression vector and 5 μg of pCG_IRES eGFP constructs expressing eGFP alone or together with Vpu. Two days post-transfection CD1d or NTB-A expression was examined by FACS analysis, essentially as described previously ([@bib27]). A phycoerythrin-conjugated anti-CD1d antibody (BD 550255) or an APC-conjugated anti-SLAM6 antibody (R&D FAB19081A) were used for staining. Fluorescence of stained cells was detected by two-color flow cytometry and Vpu-mediated down-modulation of the respective protein was calculated. Briefly, the mean fluorescence intensities were determined for cells showing specific ranges of eGFP expression. The fluorescence values obtained for cells transfected with the control construct expressing only eGFP was compared with the corresponding number obtained for cells coexpressing Vpu and eGFP to determine the efficiency of CD1d or NTB-A down-modulation.

To determine the effect of Vpu and Nef on CD4, HEK293T cells were transfected with 0.05 μg of the CD4 expression vector and 0.15 μg of pCG_IRES eGFP constructs expressing eGFP alone or together with Vpu or Nef. Two days post- transfection CD4 expression was examined by FACS analysis. A PE/Cy5 anti-human CD4 Antibody (BioLegend) was used for staining. Fluorescence of stained cells was detected by two-color flow cytometry and quantified as described above.

To determine the effect of Nef on CD28, HEK293T cells were transfected with 1 μg of the CD28 expression vector and 0.15 μg of pCG_IRES eGFP constructs expressing eGFP alone or together with Nef. Two days post-transfection CD28 expression was examined by FACS analysis. APC-conjugated anti-human CD28 antibody (CD28.2, BD Biosciences) was used for staining.

To determine the effect of Nef on MHC I, HeLa.B27 cells \[a kind gift from Anthony Antoniou\] were transfected with 0.5 μg of pCG_IRES eGFP constructs expressing eGFP alone or together with Nef. Two days post-transfection MHC I expression was examined by FACS analysis. A PE/Cy5 anti-human HLA-A,B,C antibody, clone W6/32 (BioLegend) was used for staining. Fluorescence of stained cells was detected by two-color flow cytometry and quantified as described above.

NF-κB reporter assay {#s0070}
--------------------

Transfections for luciferase assays were performed in 96-well plates and each transfection was performed in triplicate as described before ([@bib27]). Briefly, Vpu expression plasmids (100 ng) were transfected in HEK293T cells along with a plasmid expressing human tetherin or a constitutively active mutant of IKKβ (40 ng), an NF-κB-dependent firefly luciferase construct (100 ng) and a pTAL promoter *gaussia* luciferase reporter plasmid (25 ng). 40 h post-transfection, dual luciferase assays were performed. Firefly luciferase signals were normalized to the corresponding *gaussia* luciferase signals.

Luciferase reporter virus assay {#s0075}
-------------------------------

HEK293T cells were co-transfected with 0.3 μg of p8.91 HIV-1 gag-pol expression vector, 0.3 μg VSV-G, and 0.45 μg of pCSLUCW retroviral expression vector encoding luciferase. For tetherin counteraction experiments, 0.25 μg of T/F or CC Vpu constructs were co-transfected with 0.05 μg of tetherin, or empty vector (pcDNA3.1). 48 h post-transfection, viral supernatants were harvested, filtered using 0.45 µm pore-sized filters and used to infect TZM-bl cells. Luciferase activity of the TZM-bl cells was measured 24 h post-infection using the Steady Glo Firefly Luciferase assay (Promega) and GloMax96 Luminometer (Promega).

Nef infectivity assay {#s0080}
---------------------

HEK293T cells were cotransfected with 0.4 μg pBR_HIV-1 M NL4-3 (*nef* STOP) and 2 μg of pCG_Nef IRES eGFP in six well plates using the Calcium phosphate method. Virus was harvest from supernatant 48 h post-transfection and normalized using p24^Gag^ ELISA. Normalized virus was used to infect indicator TZM-bl cells and β-galactosidase activity measured 72 h post-infection using Gal-screen substrate (Applied Biosystems, USA).

A3F/G restriction assay {#s0085}
-----------------------

HEK293T cells were co-transfected with *vif*-deficient NL4-3 ([@bib23]) and T7-A3F/G ([@bib2]) at a 1:1 ratio. Cells were also co-transfected with plasmids encoding HA-tagged Vif proteins from T/F and CC viruses. 48 h after transfection, supernatants containing viruses were harvested, filtrated through a 45 μm pore-sized filter and quantified using a p24^Gag^ ELISA (Perkin Elmer). Viruses were then used to infect indicator TZM-bl cells and luciferase activity was measured 48 h post-infection. Producer cells were lysed in RIPA buffer (50 mM Tris--HCl pH 7.4, 100 mM NaCl, 1 mM MgCl~2~, 1% NP-40, 0.1% SDS and 0.5% sodium deoxycholate). Protein expression was assessed by standard immuno blot, anti HA (3F10, Roche) to identify HA-tagged Vif and anti-HSP90 (H114, Santa Cruz Biotechnology). Proteins were then detected by Li-cor Odyssey infrared imaging using IRDye800CW or IRDye 680LT-labeled secondary antibodies.

Appendix A. Supplementary materials {#s0095}
===================================

**Supplementary Figure 1:** amino acid alignment of Vpu alleles used in this study.

**Supplementary Figure 2:** amino acid alignment of Vif alleles used in this study

**Supplementary Figure 3:** amino acid alignment of Nef alleles used in this study
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Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.virol.2015.03.015](http://dx.doi.org/10.1016/j.virol.2015.03.015){#ir0005}.

![Vpu-mediated counteraction of tetherin, inhibition of NF-κB activation and downmodulation of CD4, NTB-A and CD1d. (A) Immunoblot showing expression of T/F and CC Vpu proteins in HEK293T cells transfected with pCG *vpu* IRES eGFP expression constructs. An antibody against AU-1 was used to detect C-terminally tagged Vpu. (B) HEK293T cells were co-transfected with expression vectors for HIV-1 Gag-Pol, VSV-G, a modified HIV genome encoding firefly luciferase, Vpu and tetherin or an empty vector control. 48 h post-transfection, viral supernatants were used to infect TZM-bl cells and luciferase activity was measured 24 h post-infection. Infectious virus yield in the presence of Vpu was normalized to that in the presence of empty vector (vector control). (C and D) HEK293T cells were co-transfected with Vpu expression plasmids, along with plasmid expressing an NF-κB-dependent firefly luciferase reporter construct and a pTAL promoter *gaussia* luciferase plasmid for normalization, and either a plasmid expressing (C) human tetherin or (D) a constitutively active mutant of IKKβ. 40 h post- transfection, dual luciferase assays were performed. Firefly luciferase signals were divided by the corresponding *gaussia* luciferase signals and normalized to the vector control. **(E--J)** HEK293T cells were transfected with (E and F) CD4 (G and H) NTB-A or (I and J) CD1d expression vectors and plasmids expressing eGFP alone or together with Vpu. Two days post-transfection CD4, NTB-A or CD1d surface expression was detected by fluorophore-conjugated antibodies and examined by flow cytometry. Mean fluorescence intensities were normalized to the control construct expressing only eGFP (vector control). Each data point represents one *vpu* allele. The mean of three independent experiments ± sd is shown. In all experiments, unpaired Student׳s *t* test was performed to examine differences between T/F and CC viruses. (E,G and I) Examples of primary experimental data from flow cytometry for one T/F and CC Vpu.](gr1){#f0005}

![Vif-mediated counteraction of APOBEC3F and APOBEC3G. HEK293T cells were transfected with plasmids encoding NL4-3 Δ*vif*, APOBEC3F or G and HA-tagged Vif proteins. 48 h post-transfection, producer cells and supernatants were harvested. (A) Expression of Vif proteins in producer cells was assessed by standard immunoblot. (B and C) Virion infectivity of supernatants generated in the presence of APOBEC3F (B) or APOBEC3G (C) was determined using TZM-bl indicator cells. Luciferase values were normalized to controls without Vif (vector control). The mean of four independent replicates ±sd is shown.](gr2){#f0010}

![Nef-mediated downmodulation of CD4, CD28, MHC class I and enhancement of virion infectivity. (A) Immunoblot showing expression of T/F and CC Nef proteins in HEK293T cells transfected with pCG\_*nef* IRES eGFP expression constructs. An antibody against AU-1 was used to detect C-terminally tagged Nef. (B--E) HEK293T cells were transfected with (B and C) CD4 or (D and E) CD28 expression vector and constructs expressing eGFP alone or together with Nef. Two days post-transfection CD4 or CD28 expression was detected by flow cytometry. Mean fluorescence intensities were normalized to the control construct expressing only eGFP (vector control). (F and G) MHC class I downregulation using HeLa.B27 cells transfected with constructs expressing eGFP alone or together with Nef. Two days post-transfection MHC I expression was analyzed by flow cytometry as described above. (H) Virion infectivity enhancement by Nef was measured using HEK293T cells co-transfected with HIV-1 NL4-3 and eGFP Nef. Supernatants were harvested 48 h post-transfection and p24-normalized virus was used to infect TZM-bl cells. Infectivity was normalized to the control construct expressing no *nef* allele (vector control). The mean of at least three independent experiments ±sd is shown. (B,D and F) Example of primary experimental data from flow cytometry for one T/F and CC Nef.](gr3){#f0015}

###### 

Origins and characteristics of viruses used in this study.

  Virus    Country of origin   Gender   Transmission route   Fiebig stage   Viral load at isolation   Cd4 count at isolation   Coreceptor tropsim   TF/CC   HIV-1 subtype
  -------- ------------------- -------- -------------------- -------------- ------------------------- ------------------------ -------------------- ------- ---------------
  ZM246F   Zambia              F        Heterosexual         II             10,013,800                NA                       R5                   TF      C
  ZM247F   Zambia              F        Heterosexual         II             10,823,500                NA                       R5                   TF      C
  ZM249M   Zambia              M        Heterosexual         IV             \>2,000,000               NA                       R5                   TF      C
  CH040    USA                 M        MSM                  II             2,197,248                 NA                       R5                   TF      B
  WITO     USA                 M        Heterosexual         II             325, 064                  NA                       R5                   TF      B
  CH077    USA                 M        MSM                  II/III         394, 649                  NA                       R5/X4                TF      B
  CH432    Malawi              M        Heterosexual         NA             40,570                    261                      R5                   CC      C
  CH457    Tanzania            F        Heterosexual         NA             234,671                   450                      R5                   CC      C
  CH534    South Africa        F        Heterosexual         NA             NA                        NA                       NA                   CC      C
  RHGA     USA                 M        MSM                  NA             50,000                    571                      R5                   CC      B
  WARO     USA                 F        MSM                  NA             16,758                    598                      R5                   CC      B
  STCOr1   USA                 M        MSM                  NA             67,964                    796                      R5/X4                CC      B

Key: MSM: men who have sex with men; TF -- transmitted/founder virus; CC- Chronic virus; NA -- not available; Feibig stage as described previously ([@bib8])
